# Multi-Omics Integration & Confidence Scoring

---

## Multi-Omics Confidence Score (0-100)

### Score Components

**Data Availability (0-40 points)**:
- Genomics data available (GWAS or rare variants): 10 points
- Transcriptomics data available (DEGs or expression): 10 points
- Protein data available (PPI or expression): 5 points
- Pathway data available (enriched pathways): 10 points
- Clinical/drug data available (approved drugs or trials): 5 points

**Evidence Concordance (0-40 points)**:
- Multi-layer genes (appear in 3+ layers): up to 20 points (2 per gene, max 10 genes)
- Consistent direction (genetics + expression concordant): 10 points
- Pathway-gene concordance (genes found in enriched pathways): 10 points

**Evidence Quality (0-20 points)**:
- Strong genetic evidence (GWAS p < 5e-8): 10 points
- Clinical validation (approved drugs): 10 points

### Score Interpretation

| Score | Tier | Interpretation |
|-------|------|----------------|
| **80-100** | Excellent | Comprehensive multi-omics coverage, high confidence, strong cross-layer concordance |
| **60-79** | Good | Good coverage across most layers, some gaps |
| **40-59** | Moderate | Moderate coverage, limited cross-layer integration |
| **0-39** | Limited | Limited data, single-layer analysis dominates |

### Evidence Grading System

| Tier | Symbol | Criteria | Examples |
|------|--------|----------|----------|
| **T1** | [T1] | Direct human evidence, clinical proof | FDA-approved drug, GWAS hit (p<5e-8), clinical trial result |
| **T2** | [T2] | Experimental evidence | Differential expression (validated), functional screen, mouse KO |
| **T3** | [T3] | Computational/database evidence | PPI network, pathway mapping, expression correlation |
| **T4** | [T4] | Annotation/prediction only | GO annotation, text-mined association, predicted interaction |

---

## Phase 7: Multi-Omics Integration

**Objective**: Integrate findings across all layers to identify cross-layer genes, calculate concordance, and generate mechanistic hypotheses.

### Cross-Layer Gene Concordance Analysis

For each gene found in the analysis:

1. **Count layers**: In how many omics layers does this gene appear?
   - Genomics (GWAS, rare variants, genetic association)
   - Transcriptomics (DEGs, expression score)
   - Proteomics (PPI hub, protein expression)
   - Pathways (enriched pathway member)
   - Therapeutics (drug target)

2. **Score genes**: Genes appearing in 3+ layers are "multi-omics hub genes"

3. **Direction concordance**: Do genetics and expression agree?
   - Risk allele + upregulated = concordant gain-of-function
   - Risk allele + downregulated = concordant loss-of-function
   - Discordant = needs investigation

### Biomarker Identification

For each multi-omics hub gene, assess biomarker potential:
- **Diagnostic**: Gene expression distinguishes disease vs healthy
- **Prognostic**: Expression/variant predicts outcome (cancer prognostics from HPA)
- **Predictive**: Variant/expression predicts treatment response (pharmacogenomics)
- **Evidence level**: Number of supporting omics layers

### Mechanistic Hypothesis Generation

From the integrated data:
1. Identify the most supported biological processes (GO + pathways)
2. Map causal chain: genetic variant -> gene expression -> protein function -> pathway disruption -> disease
3. Identify intervention points (druggable nodes in the causal chain)
4. Generate testable hypotheses

### Confidence Score Calculation

Calculate the Multi-Omics Confidence Score (0-100) based on:
- Data availability across layers
- Cross-layer concordance
- Evidence quality
- Clinical validation

---

## Phase 8: Report Finalization

### Executive Summary

Write a 2-3 sentence synthesis covering:
- Disease mechanism in systems terms
- Key genes/pathways identified
- Therapeutic opportunities

### Final Report Quality Checklist

Before presenting to user, verify:
- [ ] All 8 sections have content (or marked as "No data available")
- [ ] Every data point has a source citation
- [ ] Executive summary reflects key findings
- [ ] Multi-Omics Confidence Score calculated
- [ ] Top 20 genes ranked by multi-omics evidence
- [ ] Top 10 enriched pathways listed
- [ ] Biomarker candidates identified
- [ ] Cross-layer concordance table complete
- [ ] Therapeutic opportunities summarized
- [ ] Mechanistic hypotheses generated
- [ ] Data Availability Checklist complete
- [ ] Completeness Checklist complete
- [ ] References section lists all tools used
